A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

NCT05150938 · clinicaltrials.gov ↗

COMPLETED

Status

5737

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Venous Thromboembolism in Cancer Patients

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Low molecular weight heparin (LMWH)
DRUG: vitamin K antagonist (VKA)
DRUG: other NOACs

Sponsor

Bayer

Collaborators

[object Object]